Wenqian Zhang
Key Laboratory Of Epigenetics And Oncology
Luzhou, 646000, China
Luzhou, 646000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
ADAM10: Function insights, disease implications, and promise of therapeutic targeting.
Journal: Drug discovery today
Published: February 20, 2025
ADAM10 is a key player in the diagnosis, prognosis and metastasis of non-small cell lung cancer (NSCLC).
Journal: Journal of Cancer
Published: November 19, 2024
Corrigendum: A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers.
Journal: Frontiers in immunology
Published: October 29, 2024
Evaluation of ENG/CD105 expression, methylation, immuno-response, and cordycepin (CD) regulation as a novel biomarker of breast invasive carcinoma (BRCA).
Journal: Journal of Cancer
Published: May 22, 2024
A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers.
Journal: Frontiers in immunology
Published: May 17, 2024
Tripartite motif-containing 28 (TRIM28) expression and cordycepin inhibition in progression, prognosis, and therapeutics of patients with breast invasive carcinoma.
Journal: Journal of Cancer
Published: March 02, 2024
Effect of DPP4/CD26 expression on SARS‑CoV‑2 susceptibility, immune response, adenosine (derivatives m62A and CD) regulations on patients with cancer and healthy individuals.
Journal: International journal of oncology
Published: September 21, 2022
Clinical evaluation of postoperative chemotherapy based on genetic testing in patients with stage IIIA non-small cell lung cancer.
Journal: Thoracic cancer
Published: March 04, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026